Incidence and prevalence of herpes simplex virus type 2 infection in persons seeking repeat HIV counseling and testing

被引:30
作者
Turner, KR
McFarland, W
Kellogg, TA
Wong, E
Page-Shafer, K
Louie, B
Dilley, J
Kent, CK
Klausner, J
机构
[1] Univ Calif San Francisco, San Francisco Dept Publ Hlth, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, AIDS Hlth Project, San Francisco, CA 94143 USA
关键词
D O I
10.1097/00007435-200304000-00011
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
infection, thereby enhancing the prevention of HSV-2 and HIV infections. Goal and Study Design: Using serologic specimens left over from HIV testing, we measured HSV-2 prevalence and incidence among persons who had repeatedly tested for HIV at anonymous counseling and testing sites in San Francisco during the period October 1997 through March 2000. Results: The prevalence of HSV-2 infection was 23.5% (n = 987) overall, 28.7% among women, and 24.1% among men who have sex with men (MSM). In relation to race/ethnicity, HSV-2 prevalence was highest among African Americans (34.4%). The incidence of HSV-2 infection (n = 457 person-years [PY] of follow-up) was 2.6 per 100 PY overall and 3.1 per 100 PY among MSM. All but one of the HSV-2 seroconversions occurred among MSM. In multivariate subanalysis of MSM, a self-reported sexually transmitted disease (hazards ratio [HR], 4.3; 95% CI, 1.2-16.1) and HIV seroconversion (HR, 19.4; 95% CI 3.8-99.9) during the interval between tests were correlated with HSV-2 incident infection. Conclusion: Offering HSV-2 serologic counseling and testing at HIV counseling and testing sites might help prevent the spread of both infectious diseases.
引用
收藏
页码:331 / 334
页数:4
相关论文
共 23 条
[1]  
[Anonymous], 1999, Multivariate Analysis: a Practical Guide for Clinicians
[2]   Incidence of herpes simplex virus type 2 infection in the United States [J].
Armstrong, GL ;
Schillinger, J ;
Markowitz, L ;
Nahmias, AJ ;
Johnson, RE ;
McQuillan, GM ;
St Louis, ME .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (09) :912-920
[3]  
ASCHER DP, 1993, J ACQ IMMUN DEF SYND, V6, P241
[4]   Premarket evaluation of the POCkit HSV-2 type-specific serologic test in culture-documented cases of genital herpes simplex virus type 2 [J].
Ashley, RL ;
Wald, A ;
Eagleton, M .
SEXUALLY TRANSMITTED DISEASES, 2000, 27 (05) :266-269
[5]   Premarket evaluation of a commercial glycoprotein G-based enzyme immunoassay for herpes simplex virus type-specific antibodies [J].
Ashley, RL ;
Wu, LX ;
Pickering, JW ;
Tu, MC ;
Schnorenberg, L .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (01) :294-295
[6]  
ASHLEY RL, 1998, HERPES, V5, P33
[7]   Prevalence and correlates of herpes simplex virus type 2 infection in a population-based survey of young women in low-income neighborhoods of Northern California [J].
Buchacz, K ;
McFarland, W ;
Hernandez, M ;
Klausner, JD ;
Page-Shafer, K ;
Padian, N ;
Molitor, F ;
Ruiz, JD ;
Bolan, G ;
Morrow, S ;
Katz, MH .
SEXUALLY TRANSMITTED DISEASES, 2000, 27 (07) :393-400
[8]  
DILLEY J, 2000, 13 INT AIDS C DURB J
[9]   From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection [J].
Fleming, DT ;
Wasserheit, JN .
SEXUALLY TRANSMITTED INFECTIONS, 1999, 75 (01) :3-17
[10]   Herpes simplex virus type 2 in the United States, 1976 TO 1994 [J].
Fleming, DT ;
McQuillan, GM ;
Johnson, RE ;
Nahmias, AJ ;
Aral, SO ;
Lee, FK ;
StLouis, ME .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (16) :1105-1111